Press Office

WELCOME TO OUR PRESS OFFICE.
SEE BELOW WHAT WE ARE INVOLVED IN:
  • 16 September 2021 | Lenias Hwenda | Let’s Talk about Health in Africa | Titans of Industry Episode 3 | Afrigen, a biotech with a passion for product formulation | Professor Petro Terblanche Afrigen is has got to be one of the most exciting biotech companies emerging out of Africa. Afrigen is a young company with a lot going on. The biotech is already supplying some of its products to Europeans and North American markets and it recently invested millions into building a clean room facility wand is now leading a WHO supported initiative to rapidly develop mRNA vaccines that meet PICS regulatory standards, the first of its kind on the African continent. Afrigen has a bright future ahead and it is ready to engage in significant business to business engagement with potential partners and investors. VIEW VIDEO

 

  • 21 September 2021 | Lenias Hwenda | Let’s Talk about Health in Africa | Titans of Industry Episode 4 | Afrigen is now ready for significant business-business partnership | Prof. Petro Terblanche, Managing Director Afrigen Biologics and Vaccines Description Afrigen is one of the most exciting biotechnology companies coming out of Africa which already has a significant footprint in the market for adjuvants and delivery systems formulations. In this conversation Professor Terblanche explains that African has been operating quietly for some years developing and formulating products but this biotech is now ready to begin engaging with investors and other partners who can speed up its growth. VIEW VIDEO

 

  • 23 September 20201 | Lenias Hwenda | Let’s Talk about Health in Africa | Titans of Industry Episode 5 | Afrigen seeking tech partners with scale, process, QA & QC experience | Petro Terblanche Description The Managing Director of Afrigen biologicals and vaccines, Professor Petro Terblanche explains Afrigen a unique Africa biotech company with unique attributes and the significance of Afrigen being the only biotech with adjuvant formulation capability outside Europe and the US. Few companies outside big Pharma in Europe and the US can formulate adjuvants. VIEW VIDEO